109 results on '"Gurbindo D"'
Search Results
2. CAUSES OF DEATH IN HIV-1 VERTICALLY INFECTED PAEDIATRIC PATIENTS IN MADRID (SPAIN) FROM 1982 TO 2008: OP10
3. Directorio de pruebas diagnósticas de las inmunodeficiencias primarias
4. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades
5. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy
6. Recovery of T-cell subsets after antiretroviral therapy in HIV-infected children
7. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART
8. Clinical Relevance of Cytokine Production in HIV-1 Infection in Children on Antiretroviral Therapy
9. Immunological and virological effects of highly active antiretroviral therapy in two HIV-1 infected children
10. Correlación entre carga viral elevada y concentraciones de TNF-α y cICAM-1 en el plasma de niños infectados por el VIH-1
11. Manifestaciones clínicas y marcadores biológicos en la historia natural de la infección por el VIH-1 en niños infectados verticalmente. Estudio longitudinal
12. Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency
13. The immunological and virological consequences of planned treatment interruptions in children with HIV infection
14. Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
15. [Prognostic markers of survival in infants younger than 12 month of age vertically infected by human immunodeficiency virus]
16. Dynamics of progression markers in a non-study population of human immunodeficiency virus-1 vertically infected infants with different antiretroviral treatments
17. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades
18. Viral Load and CD4+ T Lymphocyte Response to Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children: An Observational Study
19. Disruption in cytokine and chemokine production by T‐cells in vertically HIV‐1‐infected children
20. Immune reconstitution after in utero bone marrow transplantation in a fetus with severe combined immunodeficiency with natural killer cells
21. Correlation of Viral Load and CD8 T-Lymphocytes with Development of Neurological Manifestations in Vertically HIV-1-Infected Infants. A Prospective Longitudinal Study
22. Dynamics of progression markers in a non-study population of human immunodeficiency virus-1 vertically infected infants with different antiretroviral treatments.
23. Naïve and memory CD4[sup +] T cells and T cell activation markers in HIV-1 infected children on HAART.
24. IgD antibodies: in vitro blocking activity of IgE mediated reactions.
25. Adenoidal tissue mass as a clinical guide of disease evolution in vertically HIV-1 infected children
26. Prognostic markers of progression to aids in infants vertically infected by human immunodeficiency virus type-1,Marcadores predictivos de progresión a sida en niños infectados por transmisión vertical por el virus de la inmunodeficiencia humana tipo 1
27. The effects on infants of potent antiretroviral therapy during pregnancy: A report from Spain
28. Dynamics of progression markers in a non-study population of human immunodeficiency virus-1 vertically infected infants with different antiretroviral treatments
29. An ecological analysis and the maternal profile of vertical HIV transmission in the Community of Madrid from 1980 until 2008,Análisis ecológico y perfil materno de la transmisión vertical del virus de la inmunodeficiencia humana en la Comunidad de Madrid desde 1980 hasta 2008
30. [Clinical manifestations and biological markers in the natural history of HIV-1 infection in vertically infected children. Longitudinal study]
31. An ecological analysis and the maternal profile of vertical HIV transmission in the Community of Madrid from 1980 until 2008 | Análisis ecológico y perfil materno de la transmisión vertical del virus de la inmunodeficiencia humana en la Comunidad de Madrid desde 1980 hasta 2008
32. Prognostic markers of survival in infants younger than 12 months vertically infected by human immunodeficiency virus type-1 | Marcadores predictivos de supervivencia en niños menores de 12 meses de edad infectados verticalmente por el virus de la inmunodeficiencia humana
33. Prognostic markers in naive infants younger than two months of age with HIV-1 infection
34. A socio-economic and demographic analysis of the prevalence of paediatric HIV due to vertical transmission in the Community of Madrid | Análisis socioeconómico y demográfico de la prevalencia en niños infectados por el virus de la inmunodeficiencia humana por transmisión vertical en la Comunidad de Madrid
35. Relationship between T-cells subsets and prognostic markers in HIV-1-infected children | Relación de las subpoblaciones de linfocitos T con los marcadores pronósticos de la infección pediátrica por el virus de la inmunodeficiencia humana
36. [Correlation between high plasma viral load and levels of TNF-alpha and cICAM-1 in HIV-1 infected children]
37. Immunologic recovery after 2-years on HAART in vertically HIV-infected children
38. A socio-economic and demographic analysis of the prevalence of paediatric HIV due to vertical transmission in the Community of Madrid,Análisis socioeconómico y demográfico de la prevalencia en niños infectados por el virus de la inmunodeficiencia humana por transmisión vertical en la Comunidad de Madrid
39. [Expression of different HIV-1 phenotypic subpopulations through the natural history of the infection]
40. Responses to antiretroviral treatments in vertically HIV-1-infected children | Respuesta al tratamiento antirretroviral en niños infectados verticalmente por el virus de la inmunodeficiencia humana tipo 1
41. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
42. Multicenter study for the evaluation of the antibody response against salmonella typhi Vi vaccination (EMPATHY) for the diagnosis of Anti-polysaccharide antibody production deficiency in patients with primary immunodeficiency.
43. Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome.
44. Rate of candidiasis among HIV-infected children in Spain in the era of highly active antiretroviral therapy (1997-2008).
45. Preterm neonates show marked leukopenia and lymphopenia that are associated with increased regulatory T-cell values and diminished IL-7.
46. A leaky mutation in CD3D differentially affects αβ and γδ T cells and leads to a Tαβ-Tγδ+B+NK+ human SCID.
47. Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome.
48. Slow progression of human immunodeficiency virus and hepatitis C virus disease in a cohort of coinfected children.
49. Positive virological outcome after lopinavir/ritonavir salvage therapy in protease inhibitor-experienced HIV-1-infected children: a prospective cohort study.
50. The effects on infants of potent antiretroviral therapy during pregnancy: a report from Spain.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.